<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>27720238</identifier>
<setSpec>1578-1275</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Rodríguez-Arrondo, Francisco</dc:author>
<dc:author>Santamaría Mas, María Isabel</dc:author>
<dc:author>Ibarguren Pinilla, Maialen</dc:author>
<dc:author>García Gonzalo, Maria Asunción</dc:author>
<dc:author>Pascual Tomé, Lidia</dc:author>
<dc:description xml:lang="en">AIM To assess the prevalence of comorbidities, concomitant therapies and adverse effects associated with the medication in a cohort of patients with HIV infection. DESIGN Multicentre cross-sectional study. SETTINGS Infectious Diseases or Internal Medicine outpatient Clinics of 3 hospitals in the Basque Country. PARTICIPANTS During a 3 month period, patients with the following inclusion criteria were randomly selected: HIV infection, age&gt;18years, antiretroviral treatment (ART) for at least 6months, and no changes in ART in the previous 4weeks. A total of 224 patients (of the 225 expected) were included. MEASUREMENTS Data were collected using a form, and include, epidemiological and anthropometric data, data related to HIV infection, comorbidities, current therapies, and adverse effects. RESULTS Of the 224 patients, 95.5% had at least one comorbidity, the most common being HCV infection (51.3%), dyslipidaemia (37.9%), diabetes mellitus or impaired fasting glucose (21.9%), and hypertension (21.9%). A total of 155 patients (69.2%) were taking concomitant medication: anxiolytics (21.4%), antihypertensives (19.6%), proton pump inhibitors (17.9%), statins (17%), and antidepressants (16.5%). Adverse effects (AE) were observed in 62.9% of subjects, the most common being, changes in body fat distribution (32.6%) and gastrointestinal (24.1%). CONCLUSIONS Patients with HIV infection are getting older, with more comorbidities, with very frequent use of concomitant treatments, and high number of adverse effects. This requires a multidisciplinary approach and a coordinated effort within the Primary Care setting.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:subject>Tratamientos concomitantes</dc:subject>
<dc:subject>Tratamiento antirretroviral</dc:subject>
<dc:subject>Comorbidity</dc:subject>
<dc:subject>Comorbilidades</dc:subject>
<dc:subject>Human immunodeficiency virus</dc:subject>
<dc:subject>Virus de la inmunodeficiencia humana</dc:subject>
<dc:subject>Antiretroviral therapy</dc:subject>
<dc:subject>Concomitant medications</dc:subject>
<dc:date>2017 May </dc:date>
<dc:title xml:lang="es">Estudio transversal de comorbilidades y medicaciones concomitantes en una cohorte de pacientes infectados por el virus de la inmunodeficiencia humana.</dc:title>
<dc:title xml:lang="en">[Cross sectional study of comorbidities and concomitant medications in a cohort of human immunodeficiency virus-infected patients].</dc:title>
<dc:publisher>Atencion primaria</dc:publisher>
</metadata>
</record>
</pubmed-document>
